MedTrace Logo

Late Clinical Outcomes of Percutaneous Mitral Commissurotomy in Patients With Mitral Stenosis

NCT04112108 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2019-10-02

No results posted yet for this study

Summary

In this retrospective cohort study, out of 220 patients who had undergone successful PTMC between 2006 and 2018, the clinical course of 186 patients could be successfully followed. Peri-procedural clinical and echocardiographic data were collected for these patients. Cardiac-related death, undergoing a second PTMC or mitral valve replacement (MVR) were considered adverse cardiac events in follow-up for the purpose of this study. Patients with no history of these events were contacted and asked to undergo echocardiographic imaging, in order to assess the prevalence of mitral valve restenosis, defined as mitral valve area (MVA) \< 1.5 cm2 and loss of ≥50% of initial area gain

Conditions

  • Mitral Valve Stenosis

Interventions

PROCEDURE

PTMC

percutaneous mitral ballooning with Inoue balloon

Sponsors & Collaborators

  • Baqiyatallah Medical Sciences University

    collaborator OTHER

  • Shiraz University of Medical Sciences

    lead OTHER

Eligibility

Min Age
35 Years
Max Age
52 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2018-09-01
Completion
2018-09-20

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04112108 on ClinicalTrials.gov